Second November 2014 Huge Mesh Loss for Boston Scientific

On November 20, 2014, a jury in Charleston, West Virginia Federal court found the Massachusetts Company liable to four women following a 10-day trial and determined damages for each of the four women ranging from $3.25 million to $4.25 million for the injuries.  The women used the company’s Obtryx device (Obtryx Transobturator Mid-Urethral Sling System) [...]

November 21st, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Second November 2014 Huge Mesh Loss for Boston Scientific

$27 Million Dollar Mesh Verdict Against Boston Scientific

A Federal jury in Miami, Florida awarded $27 million to four women who were injured by defective mesh product manufactured by Boston Scientific.  Boston Scientific will not face additional punitive damages.  The jury returned a verdict finding negligence by Boston Scientific with the Pinnacle Pelvic Floor Repair Kit.  The jury found that this product was [...]

November 18th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on $27 Million Dollar Mesh Verdict Against Boston Scientific

Endo’s American Medical Scientific Mesh Unit Settles 20,000 Cases for $830 Million

Seeing the writing on the wall, Endo International announced on May 1, 2014 that they will pay $830 million to settle 20,000 cases involving women implanted with the AMS transvaginal mesh unit. Click here to read the full article: Endo’s AMS Unit Settles 20,000 Vaginal Mesh Cases for $830M This settlement will resolve most of [...]

May 7th, 2014|Transvaginal Mesh|Comments Off on Endo’s American Medical Scientific Mesh Unit Settles 20,000 Cases for $830 Million

Due to Numerous Injuries, FDA Proposes Reclassifying Vaginal Mesh Devices from Class 2 to Class 3

Based on a number of risks associated with the transvaginal mesh devices including infection, vaginal bleeding, damage to connective tissues, nerves, and blood vessels, on May 1, 2014, the FDA proposed reclassification of mesh devices from Class 2 to the more rigorous Class 3 status. "The FDA has identified clear risks associated with surgical mesh [...]

May 5th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Due to Numerous Injuries, FDA Proposes Reclassifying Vaginal Mesh Devices from Class 2 to Class 3

Dallas Jury Awards $1.2 Million Verdict Against Johnson and Johnson’s Ethicon

In another victory for plaintiffs against vaginal-mesh implant manufacturers, a Dallas jury found for the plaintiff Linda Batiste and ordered Johnson & Johnson to pay $1.2 million in compensatory damages.  The jury declined to award punitive damages. (Batiste v. McNabb, No. 12-14350, District Court for the 95th Judicial District, Dallas County Texas (Dallas)). The jury [...]

April 9th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Dallas Jury Awards $1.2 Million Verdict Against Johnson and Johnson’s Ethicon

A Brief Review of The Trial Testimony and Directed Verdict for Ethicon in Carolyn Lewis Mesh Bellwether Case

On February 18, 2014, Judge Joseph Goodwin granted Ethicon’s Motion for Directed Verdict at the close of Plaintiff’s case in Lewis vs. Ethicon, Inc. (In Re:  Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL Docket No. 2327, Carolyn Lewis, et al. v. Johnson & Johnson, et al., No. 2:12-4301, S.D. W.Va.). What is a [...]

February 19th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on A Brief Review of The Trial Testimony and Directed Verdict for Ethicon in Carolyn Lewis Mesh Bellwether Case

Johnson & Johnson Mesh Trial Set to Begin

The first trial against Johnson & Johnson’s line of vaginal mesh products was set to commence February 10, 2014 in U.S. District in West Virginia.  Judge Joseph Goodwin will preside over the case, Carolyn Lewis, et al. v. Johnson & Johnson, et al., 2:12-cv-04301 TVT.  Lewis alleges complaints over Johnson & Johnson’s Ethicon-produced TVT Retropubic [...]

February 11th, 2014|Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Johnson & Johnson Mesh Trial Set to Begin